COVID-19和帕金森病:单中心研究和门德尔随机化研究
Jianhong Yin1, Song Zhang2, Qian Zheng3
1Department of Neurology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, China.
Scientific reports
|July 17, 2024
概括
帕金森病患者的持续时间较长,最近没有接种疫苗,面临更高的COVID-19感染风险. 在帕金森病患者中,COVID-19感染可能会使运动症状恶化.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 遗传学 是一个遗传学.
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病.
- COVID-19对PD患者的影响需要进一步调查.
- 了解这些关联对于患者护理和公共卫生至关重要.
研究的目的:
- 为了调查COVID-19和帕金森病 (PD) 之间的关联.
- 在PD患者中识别COVID-19感染的风险因素.
- 探索COVID-19对PD症状和易感性的影响.
主要方法:
- 一个单一的中心,基于问卷调查的PD患者.
- 对感染风险因素进行后勤回归分析.
- 双向双样本门德尔随机化 (MR) 评估因果关系.
主要成果:
- 在PD患者中,COVID-19的患病率为65.7%;35.3%的患者经历了运动症状恶化.
- 长期PD疾病持续时间 (≥10年) 和上次接种疫苗以来的时间 (>12个月) 是感染的重要风险因素.
- 核磁共振分析表明,PD增加了COVID-19的易感性 (OR=1.084,P=0.006),但不是严重程度或住院. 没有观察到COVID-19对PD的显著影响.
结论:
- 在COVID-19感染后,PD患者可能会出现运动症状恶化.
- 长时间的疾病持续时间和延迟接种疫苗是PD感染的关键风险因素.
- 有证据表明,PD与增加COVID-19易感性有关.
更多相关视频
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.5K
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
2.8K
相关概念视频
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
Parkinson's Disease: Overview
517
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
517
Parkinson's Disease: Treatment
244
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
244
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K
